US2024026342A1PendingUtilityA1
Inhibition of unintended mutations in gene editing
Est. expiryFeb 2, 2039(~12.6 yrs left)· nominal 20-yr term from priority
C12N 15/102C12N 9/22C12N 9/506C12N 9/78C12N 15/111C12N 2310/20C07K 2319/50C07K 2319/85C12Y 304/22044C12Y 305/04004C12Y 305/04005C12N 15/1137C12N 15/85C12Y 304/21111C12N 2800/107C12N 15/90C12N 15/113
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are fusion proteins and related molecules useful for conducting base editing with reduced or no off-target mutations. The fusion protein may include a first fragment comprising a nucleobase deaminase or a catalytic domain thereof, a second fragment comprising a nucleobase deaminase inhibitor, and a protease cleavage site between the first fragment and the second fragment. Also provided are improved prime editing systems, including prime editing guide RNA with improved stability.
Claims
exact text as granted — not AI-modified1 . A pair of helper guide RNA/guide RNA for editing a human PCSK9 nucleic acid sequence, wherein the guide RNA specifically targets a first site on the PCSK9 nucleic acid to enable base editing to convert a non-stop codon to a stop codon, and wherein the helper guide RNA specifically targets a second site on the PCSK9 nucleic acid that is 20 to 100 bases from the first site.
2 . The pair of helper guide RNA/guide RNA of claim 1 , wherein the non-stop codon is CAG, CAA, or CGA.
3 . The pair of helper guide RNA/guide RNA of claim 1 , wherein the helper guide RNA specifically binds to a sequence that is 7-23 nucleotides in length.
4 . The pair of helper guide RNA/guide RNA of claim 1 , wherein the helper guide RNA specifically binds to a sequence that is 8-15 nucleotides in length.
5 . The pair of helper guide RNA/guide RNA of claim 1 , wherein the helper guide RNA specifically binds to a sequence within the first site, and the guide RNA specifically binds to a sequence within the second site.
6 . The pair of helper guide RNA/guide RNA of claim 5 , wherein the second site comprises the sequence of any one of SEQ ID NO:166-180.
7 . The pair of helper guide RNA/guide RNA of claim 5 , wherein the second site and the first site, respectively, comprises the sequences of:
SEQ ID NO:166 and 181; SEQ ID NO:167 and 182; SEQ ID NO:168 and 183; SEQ ID NO:169 and 184; SEQ ID NO:170 and 185; SEQ ID NO:171 and 186; SEQ ID NO:172 and 187; SEQ ID NO:173 and 188; SEQ ID NO:174 and 189; SEQ ID NO:175 and 190; SEQ ID NO:176 and 191; SEQ ID NO:177 and 192; SEQ ID NO:178 and 193; SEQ ID NO:179 and 194; or SEQ ID NO:180 and 195.
8 . One or more polynucleotide sequences encoding the helper guide RNA and guide RNA of claim 1 .
9 . A method of inactivating a PCSK9 gene in a cell, comprising contacting the cell with a pair of helper guide RNA and guide RNA of claim 1 , a clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas) protein, and a nucleobase deaminase.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.